Melissa J. Joliat

Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study

Stephan Chalon, Luc‐André Granier, François Vandenhende et al. · Neuropsychopharmacology · 2003 · 94 citations · Full text

Psychoactive Drug, Healthy Subjects, Psychiatry +13

Safety of Subchronic Treatment with Fluoxetine for Major Depressive Disorder in Children and Adolescents

Mary Nilsson, Melissa J. Joliat, Cherri M. Miner et al. · Journal of Child and Adolescent Psychopharmacology · 2004 · 39 citations

Establishment and characterization of a new osteogenic cell line (MOS-J) from a spontaneous C57BL/6J mouse osteosarcoma.

Melissa J. Joliat, Syuji Umeda, Bonnie Lyons et al. · PubMed · 2003 · 29 citations

Bone Morphogenic Protein, Malignant Disease, Bone Repair +10

Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment

Teri Pearlstein, Melissa J. Joliat, Eileen B. Brown et al. · American Journal of Obstetrics and Gynecology · 2003 · 25 citations

Luteal-phase Fluoxetine Treatment, Premenstrual Dysphoric Disorder, Psychiatry +8

Mechanisms of anemia in SHP-1 protein tyrosine phosphatase-deficient “viable motheaten” mice

Bonnie Lyons, Michael A. Lynes, Lisa Burzenski et al. · Experimental Hematology · 2003 · 21 citations

Signal Transduction, Molecular Physiology, Biochemistry +10